Kumasaka Y, Nakahata H, Hirai Y, Imamura K, Takebe K, Suzuki I, Senda H
Jpn J Antibiot. 1986 Jan;39(1):154-8.
Studies were done utilizing E. coli No. 59 which are resistant against human and mouse serum, and the following results were obtained. The therapeutic effect of cefbuperazone (CPBZ) against systemic infections of mice was much higher than that of cefmetazole (CMZ), cefotetan (CTT), latamoxef (LMOX) and cefoperazone (CPZ). Synergistic bactericidal effect with human polymorphonuclear leukocytes was more marked for CBPZ than CMZ.
利用对人和小鼠血清具有抗性的大肠杆菌59号进行了研究,并获得了以下结果。头孢哌酮(CPBZ)对小鼠全身感染的治疗效果远高于头孢美唑(CMZ)、头孢替坦(CTT)、拉氧头孢(LMOX)和头孢哌酮(CPZ)。与头孢美唑相比,头孢哌酮与人多形核白细胞的协同杀菌作用更为显著。